Vitamin D3 for Life

Live Enlightened

Physiology

Vitamin D and Lasting Gene Regulation: Full Evidence Review

Previous related pageVitamin D in Early Tissue and Organ Development: Full Evidence ReviewNext related pageEarly-Life Vitamin D and Childhood Immune Trajectories: Full Evidence Review
Study at a glance

What question did the studies ask?

Researchers asked whether vitamin D-related changes in gene regulation can last after the original exposure changes. A response during continuing treatment is different from a response that remains after treatment ends. DNA carries genetic information. A chemical mark on DNA is different from a change in gene activity.

What did the researchers find?

In one mouse study, cells from fetal liver were transferred into other mice with sufficient vitamin D. Some later gene-activity patterns and altered responses to insulin persisted. Insulin is a hormone that helps regulate blood sugar. The experiment did not isolate the DNA marks as the sole cause. Another mouse study found variable DNA marks in later generations, without a clear overall change in the measured neonatal gene expression. The mother mice ate a vitamin D-depleted diet. Their developing offspring included cells that later produced sperm, so those cells were directly exposed too.

Human pregnancy studies measured DNA marks at birth. They did not establish lasting changes in children’s gene activity. A year-long randomized vitamin D3 trial did not find a clear whole-blood gene-expression response under its analysis. That does not rule out responses in other tissues or at earlier times.

What does this mean?

Human biological-age scores gave mixed findings. The larger three-year trial did not show a clear vitamin D-alone effect on its four scores. These scores do not measure lifespan or persistent gene regulation after withdrawal. The evidence supports selected animal programming mechanisms, but does not establish lasting beneficial gene reprogramming in people.

Read the full article below ↓

Some mouse experiments link early vitamin D conditions to later gene-regulatory programmes, including after transplantation into a different exposure environment. Human studies provide a more qualified picture: newborn DNA marks, biological-age scores and longer-term blood RNA measurements do not demonstrate the same kind of lasting regulation. This review asks what persistence means, what was actually followed, and whether a molecular mark was shown to cause the later effect. For the shorter account, read Vitamin D and Lasting Gene Regulation: Study Summary.

Long exposure, persistent response and inheritance are different questions

Gene expression is the production of RNA from a gene and its downstream regulation. Epigenetic measurements examine features such as DNA methylation, a chemical modification of DNA, without changing the underlying sequence. A methylation difference can accompany an expression difference, but does not establish that the mark caused it. The measurement distinction is introduced in Vitamin D and Epigenetic Regulation and Vitamin D and Gene Expression.

Three designs need to be separated. A response measured during continuing treatment shows an exposure-associated state. A response that remains after the exposure context changes is stronger evidence of persistence. Transmission to a later generation raises an additional question: were that generation or its future germ cells already directly exposed? None of these questions can be answered by the word epigenetic alone. A single specimen collected at birth is not a follow-up study of later gene activity.

This focused comparison includes primary animal experiments, randomized supplementation studies and observational human analyses. It is not a meta-analysis or four independent confirmations of one lasting mechanism. The most direct persistence and generation experiments are in mice; the human studies provide important boundary tests. Oral vitamin D3, calcitriol treatment, receptor manipulation and a developmental deficiency model are distinct exposures. Blood vitamin D status alone also cannot identify a persistent cellular effect, as explained in Vitamin D Status vs Vitamin D Effect.

Mouse developmental programming survives a changed environment

Oh and colleagues compared fetal material from vitamin D-deficient and sufficient mouse dams. Whole fetal liver cells, which included blood-forming stem cells, were transplanted into irradiated vitamin-D-sufficient recipients. They were not purified stem-cell transplants. Later macrophage analyses, metabolic measurements and secondary transplantation tested whether the earlier exposure environment was associated with a retained donor-derived programme. Selected expression and metabolic features persisted for months and through secondary transfer. [1]

The experiments therefore go beyond observing a mark while the original deficiency continues. However, transplantation and irradiation create a specialised environment, and whole fetal liver includes more than one cell population. The results cannot automatically identify a single initially exposed cell class as the sole cause. Nor do they show that every tissue has the same programme. The lineage question connects this study to Vitamin D and Cell Differentiation, while the observed metabolic phenotype belongs within the separate physiology of Vitamin D and Insulin Signalling. [1]

Targeted analysis of 69 CpG sites, using small groups of four, found greater methylation in a Jarid2 region alongside lower Jarid2 expression. JARID2 is a PRC2-associated regulatory protein, not itself the catalytic histone methyltransferase of that complex. Jarid2 and downstream pathway perturbations supported a regulatory contribution. The investigators did not selectively edit or rescue those CpG marks, so the specific DNA methylation change was not isolated as the necessary cause of persistent programming. [1]

The proposed communication to fat cells also requires precision. Neutralising selected inflammatory cytokines did not rescue the insulin-resistance response in the adipocyte experiment. The microRNA miR-106b-5p experiments supplied a different supported route. A microRNA is a small RNA that can regulate other gene messages. These findings do not justify replacing the measured pathway with a generic inflammation explanation. Internal timing differences between text, captions and some metabolic assays also limit precise time-point comparisons. [1]

A component involving 30 mothers and cord-monocyte samples was observational and contemporaneous. Conditioned-cell experiments included responses measured in mouse adipocyte cultures, not subsequent disease in the children. There was no human childhood diabetes follow-up or human methylation-memory test. The mouse evidence supports developmental programming within that experimental system, not a demonstrated inherited human metabolic benefit from supplementation. [1]

Later-generation methylation is not automatically unchanged inheritance

Xue and colleagues depleted maternal vitamin D before conception and through pregnancy and lactation in crossed mouse strains. First-generation offspring received normal food after weaning; adult males were then crossed with unexposed females to produce the next generation. The investigators measured selected imprinted loci, regions where parent-of-origin regulation is important, in liver and sperm and examined neonatal gene expression. [2]

Methylation varied by locus, tissue, sex and strain cross. Many differences were small, and some disappeared or new ones emerged across generations. This was not demonstration of one identical mark passed unchanged through a family line. Crucially, the measured total expression of the selected imprinted genes did not show a significant overall dietary effect in second-generation neonatal liver. A persistent or later-generation mark therefore did not necessarily produce a detected overall expression change. [2]

The first generation’s germ cells were directly exposed during maternal treatment. An effect in their offspring does not establish a wholly unexposed third-generation inheritance mechanism. No targeted methylation rescue proved the marks caused a functional phenotype. This study is distinct from the transplantation programme, but its generations, tissues and loci are related components of one experiment, not separate replications. [2]

Human marks at birth do not show later persistence

The MAVIDOS trial randomized pregnant women to 1,000 international units of vitamin D3 daily or placebo and measured RXRA-region DNA methylation in 453 newborn cord-tissue samples. One site had an estimated 1.98-percentage-point lower methylation, but the overall results did not meet a 0.05 significance threshold after adjustment for the tested sites. Seasonal subgroup findings and unmeasured cord-cell composition add uncertainty. The trial excluded very low baseline vitamin D status, limiting transfer to severe deficiency. [3]

Even if a birth difference were secure, one birth specimen would not show how long it remained, whether RXRA expression changed later, or whether it mediated a physiological outcome. The separate placental-explant component used 25-hydroxyvitamin D rather than the randomized oral vitamin D3 regimen. Neither that experiment nor methylation: bone associations turn the cord finding into demonstrated long-term offspring gene control. [3]

The PACE consortium analysed prenatal vitamin D status and cord-blood methylation across seven cohorts and more than 3,200 mother: child pairs. No CpG association survived the relevant multiple-testing adjustment. Blood-cell adjustment and the mainly European-ancestry analysis define its population context. The null limits a broad generalized newborn blood signature, but cannot rule out other tissues, poorly represented severe deficiency or unmeasured critical windows. [4]

PACE was observational and measured the newborn state, not expression persisting after a randomized exposure ended. It also reused cohorts from earlier analyses, so those earlier papers are not independent confirmations. A small reported-versus-tabulated sample-total mismatch remains unresolved. MAVIDOS and PACE thus contribute different human boundary evidence; neither is a direct longitudinal demonstration of lasting expression in children. [4] [3]

A longer randomized exposure with no clear whole-blood RNA response

The BEST-D study randomized 305 older adults to 2,000 or 4,000 international units of vitamin D3 daily or placebo for 12 months. The RNA analysis included 298 participants with available samples, with fewer complete paired measurements. Blood vitamin D levels rose substantially in the active groups. Yet the controlled analysis found no genes meeting a 5% false-discovery threshold for altered whole-blood expression, and no clear change in the selected cytokine measurements. [5]

This trial directly limits translating short cell experiments or molecular marks into a large, sustained whole-blood expression response under those human conditions. It is not proof of no possible gene response anywhere. Whole blood mixes cell types, rare-cell changes can be diluted, and a late sample can miss an earlier response. Participants were not a population with uniformly severe deficiency. Most importantly for this question, continuing exposure for a year is not a withdrawal test, and RNA measurement is not an epigenetic-mark assay. [5]

The design therefore contributes a material null, not a missing positive result to be ignored. It answers a different question from mouse transplantation: whether these regimens alter the measured late human blood transcriptome, rather than whether a developmental programme survives transfer to sufficient recipients. Neither design can replace the other. [5] [1]

Biological-age clocks are not lasting gene-expression measurements

In the DO-HEALTH methylation substudy, 777 older Swiss participants were followed over three years. The parent trial randomized different combinations of vitamin D3 versus placebo, omega-3 versus placebo and an exercise comparison. Vitamin D3 was given at 2,000 international units daily. Vitamin D alone did not show a clear effect on the four assessed DNA methylation clocks; their confidence intervals included no effect. Omega-3 or combination findings cannot be attributed to vitamin D alone. [6]

A methylation clock is an algorithmic age-related score, not a measurement of expression at a specific gene. The broader ageing context is described in Vitamin D and Age-Related Decline. These scores also do not directly measure the stable growth arrest discussed in Vitamin D and Cellular Senescence. Three years of exposure does not establish a response after withdrawal, and a clock difference is not an observed extension of lifespan or proof of tissue renewal. [6]

Vetter and colleagues found mixed clock associations in an observational analysis of self-selected supplement users in the Berlin Aging Study II. Sixty-three users were matched with 63 non-users; the follow-up setting spanned approximately 7.4 years. The regimen was not sufficiently specified for a dose-effect inference, and health behaviour, season and other confounding remain important. Some clocks favoured users while others were null. [7]

A separate small randomized trial by Chen and colleagues reported mixed positive clock findings in overweight or obese African-American adults with suboptimal vitamin D status. It used monthly dosing for 16 weeks, with methylation assessed in a selected subset. Baseline differences and multiple comparisons constrain interpretation. The positive findings should not be omitted, but they do not measure post-withdrawal expression, a lasting mechanism at a particular locus or clinical rejuvenation. [8]

The human clock evidence is therefore mixed rather than uniformly null. Its relevance is indirect: it tests proposed ageing-associated readouts during follow-up, not the complete causal chain from a vitamin D-induced epigenetic change to enduring gene activity and function. A persistent mark would also not automatically be beneficial. The processes in Vitamin D and Regeneration require their own relevant structural or functional evidence. [6] [7] [8]

A hierarchy of persistence evidence

Study typeWhat it can contributeMissing step for a stronger lasting-regulation claim
Mouse transplantation and pathway perturbationA retained donor-derived programme after exposure context changesSelective proof that the measured CpG marks cause persistence, and human translation
Mouse later-generation lociMethylation variation across related generationsAn unchanged causal mark in a wholly unexposed generation and a functional expression consequence
Randomized newborn cord tissueAn intervention-associated state at birth, with statistical qualificationsLater follow-up, expression and mediation
Observational newborn cohortsA population boundary against broad methylation associationsRandomized exposure and longitudinal gene activity
Twelve-month randomized blood RNAA controlled late-expression null under continuing treatmentCell-specific or earlier responses and persistence after withdrawal
Human DNA methylation clocksMixed age-score findings during follow-upSpecific lasting gene control and clinically meaningful function

The strongest direct evidence for retained programming comes from selected mouse experiments, with incomplete isolation of the specific methylation cause. Human birth marks, clocks and late blood RNA studies add useful qualifications without demonstrating durable human gene reprogramming after exposure ends. More elapsed time is not the same as evidence of biological memory. A sound lasting-regulation claim must identify what persisted, in which cells, after which exposure change, and with what measured functional consequence.

Scientific sources

[1] Embryonic vitamin D deficiency programs hematopoietic stem cells to induce type 2 diabetes. Oh J, Riek AE, Bauerle KT, Dusso A, McNerney KP, Barve RA, Darwech I, Sprague JE, Moynihan C, Zhang RM, Kutz G, Wang T, Xing X, Li D, Mrad M, Wigge NM, Castelblanco E, Collin A, Bambouskova M, Head RD, Sands MS, Bernal-Mizrachi C. Nature communications. 2023;14(1):3278. DOI 10.1038/s41467-023-38849-z; PMID 37311757; PMCID PMC10264405.

[2] Maternal vitamin D depletion alters DNA methylation at imprinted loci in multiple generations. Xue J, Schoenrock SA, Valdar W, Tarantino LM, Ideraabdullah FY. Clinical epigenetics. 2016;8:107. DOI 10.1186/s13148-016-0276-4; PMID 27777636; PMCID PMC5062906.

[3] Gestational Vitamin D Supplementation Leads to Reduced Perinatal RXRA DNA Methylation: Results From the MAVIDOS Trial. Curtis EM, Krstic N, Cook E, D’Angelo S, Crozier SR, Moon RJ, Murray R, Garratt E, Costello P, Cleal J, Ashley B, Bishop NJ, Kennedy S, Papageorghiou AT, Schoenmakers I, Fraser R, Gandhi SV, Prentice A, Javaid MK, Inskip HM, Godfrey KM, Bell CG, Lillycrop KA, Cooper C, Harvey NC, MAVIDOS Trial Group. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2019;34(2):231-240. DOI 10.1002/jbmr.3603; PMID 30321476; PMCID PMC6372078.

[4] Epigenome-wide meta-analysis of prenatal vitamin D insufficiency and cord blood DNA methylation. Diemer EW, Tuhkanen J, Sammallahti S, Heinonen K, Neumann A, Robinson SL, Suderman M, Jin J, Page CM, Fore R, Rifas-Shiman SL, Oken E, Perron P, Bouchard L, Hivert MF, Räikköne K, Lahti J, Yeung EH, Guan W, Mumford SL, Magnus MC, Håberg S, Nystad W, Parr CL, London SJ, Felix JF, Tiemeier H. Epigenetics. 2024;19(1):2413815. DOI 10.1080/15592294.2024.2413815; PMID 39418282; PMCID PMC11487971.

[5] Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial. Berlanga-Taylor AJ, Plant K, Dahl A, Lau E, Hill M, Sims D, Heger A, Emberson J, Armitage J, Clarke R, Knight JC. EBioMedicine. 2018;31:133-142. DOI 10.1016/j.ebiom.2018.04.010; PMID 29685792; PMCID PMC6013786.

[6] Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial. Bischoff-Ferrari HA, Gängler S, Wieczorek M, Belsky DW, Ryan J, Kressig RW, Stähelin HB, Theiler R, Dawson-Hughes B, Rizzoli R, Vellas B, Rouch L, Guyonnet S, Egli A, Orav EJ, Willett W, Horvath S. Nature aging. 2025;5(3):376-385. DOI 10.1038/s43587-024-00793-y; PMID 39900648; PMCID PMC11922767.

[7] Vitamin D supplementation is associated with slower epigenetic aging. Vetter VM, Sommerer Y, Kalies CH, Spira D, Bertram L, Demuth I. GeroScience. 2022;44(3):1847-1859. DOI 10.1007/s11357-022-00581-9; PMID 35562603; PMCID PMC9213628.

[8] Effects of Vitamin D3 Supplementation on Epigenetic Aging in Overweight and Obese African Americans With Suboptimal Vitamin D Status: A Randomized Clinical Trial. Chen L, Dong Y, Bhagatwala J, Raed A, Huang Y, Zhu H. The journals of gerontology. Series A, Biological sciences and medical sciences. 2019;74(1):91-98. DOI 10.1093/gerona/gly223; PMID 30256915; PMCID PMC6612014.

Related reading

Original sources

Source

Embryonic vitamin D deficiency programs hematopoietic stem cells to induce type 2 diabetes

Environmental factors may alter the fetal genome to cause metabolic diseases.

Publication details

[1] Embryonic vitamin D deficiency programs hematopoietic stem cells to induce type 2 diabetes. Oh J, Riek AE, Bauerle KT, Dusso A, McNerney KP, Barve RA, Darwech I, Sprague JE, Moynihan C, Zhang RM, Kutz G, Wang T, Xing X, Li D, Mrad M, Wigge NM, Castelblanco E, Collin A, Bambouskova M, Head RD, Sands MS, Bernal-Mizrachi C. Nature communications. 2023;14(1):3278. DOI 10.1038/s41467-023-38849-z; PMID 37311757; PMCID PMC10264405.

Read more →
Source

Gestational Vitamin D Supplementation Leads to Reduced Perinatal RXRA DNA Methylation: Results From the MAVIDOS Trial

In this study, we used an existing randomized trial to test the hypothesis that maternal gestational vitamin D supplementation would lead to reduced perinatal RXRA locus DNA methylation.

Publication details

[3] Gestational Vitamin D Supplementation Leads to Reduced Perinatal RXRA DNA Methylation: Results From the MAVIDOS Trial. Curtis EM, Krstic N, Cook E, D’Angelo S, Crozier SR, Moon RJ, Murray R, Garratt E, Costello P, Cleal J, Ashley B, Bishop NJ, Kennedy S, Papageorghiou AT, Schoenmakers I, Fraser R, Gandhi SV, Prentice A, Javaid MK, Inskip HM, Godfrey KM, Bell CG, Lillycrop KA, Cooper C, Harvey NC, MAVIDOS Trial Group. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2019;34(2):231-240. DOI 10.1002/jbmr.3603; PMID 30321476; PMCID PMC6372078.

Read more →
Source

Epigenome-wide meta-analysis of prenatal vitamin D insufficiency and cord blood DNA methylation

We aimed to evaluate whether maternal vitamin D insufficiency during pregnancy was conditionally associated with DNA methylation in the offspring cord blood.

Publication details

[4] Epigenome-wide meta-analysis of prenatal vitamin D insufficiency and cord blood DNA methylation. Diemer EW, Tuhkanen J, Sammallahti S, Heinonen K, Neumann A, Robinson SL, Suderman M, Jin J, Page CM, Fore R, Rifas-Shiman SL, Oken E, Perron P, Bouchard L, Hivert MF, Räikköne K, Lahti J, Yeung EH, Guan W, Mumford SL, Magnus MC, Håberg S, Nystad W, Parr CL, London SJ, Felix JF, Tiemeier H. Epigenetics. 2024;19(1):2413815. DOI 10.1080/15592294.2024.2413815; PMID 39418282; PMCID PMC11487971.

Read more →
Source

Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial.

[5] Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial.

Publication details

[5] Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial. Berlanga-Taylor AJ, Plant K, Dahl A, Lau E, Hill M, Sims D, Heger A, Emberson J, Armitage J, Clarke R, Knight JC. EBioMedicine. 2018;31:133-142. DOI 10.1016/j.ebiom.2018.04.010; PMID 29685792; PMCID PMC6013786.

Read more →
Source

Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial.

[6] Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial.

Publication details

[6] Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial. Bischoff-Ferrari HA, Gängler S, Wieczorek M, Belsky DW, Ryan J, Kressig RW, Stähelin HB, Theiler R, Dawson-Hughes B, Rizzoli R, Vellas B, Rouch L, Guyonnet S, Egli A, Orav EJ, Willett W, Horvath S. Nature aging. 2025;5(3):376-385. DOI 10.1038/s43587-024-00793-y; PMID 39900648; PMCID PMC11922767.

Read more →
Source

Vitamin D supplementation is associated with slower epigenetic aging

We previously reported on an association between vitamin D deficiency and higher 7-CpG DNAmAA in participants of the Berlin Aging Study II (BASE-II).

Publication details

[7] Vitamin D supplementation is associated with slower epigenetic aging. Vetter VM, Sommerer Y, Kalies CH, Spira D, Bertram L, Demuth I. GeroScience. 2022;44(3):1847-1859. DOI 10.1007/s11357-022-00581-9; PMID 35562603; PMCID PMC9213628.

Read more →
Source

Effects of Vitamin D3 Supplementation on Epigenetic Aging in Overweight and Obese African Americans With Suboptimal Vitamin D Status: A Randomized Clinical Trial.

[8] Effects of Vitamin D3 Supplementation on Epigenetic Aging in Overweight and Obese African Americans With Suboptimal Vitamin D Status: A Randomized Clinical Trial.

Publication details

[8] Effects of Vitamin D3 Supplementation on Epigenetic Aging in Overweight and Obese African Americans With Suboptimal Vitamin D Status: A Randomized Clinical Trial. Chen L, Dong Y, Bhagatwala J, Raed A, Huang Y, Zhu H. The journals of gerontology. Series A, Biological sciences and medical sciences. 2019;74(1):91-98. DOI 10.1093/gerona/gly223; PMID 30256915; PMCID PMC6612014.

Read more →